Skip to main content
Figure 3 | World Journal of Surgical Oncology

Figure 3

From: Two-stage hepatectomy after autologous CD133+ stem cells administration: a case report

Figure 3

Volumetric preoperative study. (A, B, C) The study demonstrated a future liver remnant volume (D: FLRV) below the minimum of 40% of total liver volume (TLV). This percentage is generally accepted as the lower limit to allow an extended liver resection with a reasonable probability of success when there is an underlying disease, such as chronic hepatitis, cirrhosis or previous chemotherapy. FLRV, future liver remnant volume; TLV, total liver volume.

Back to article page